Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2025-12-25 @ 4:31 AM
NCT ID:
NCT05110118
Eligibility Criteria:
Inclusion Criteria:
* Healthy male volunteers
* Subjects aged 18 - 45 years
* Subjects weighing ≥ 50.0 kg and ≤ 100.0 kg
* Subjects with a body mass index (BMI) ≥ 19.0 and ≤ 26.0 kg/m2
Exclusion Criteria:
* Subjects with evidence or history of clinically significant disease
* Subjects with a history of previous cancer
* Subjects with a history of hypertension, or abnormal blood pressure at screening/baseline measurements (systolic blood pressure \> 140 mmHg and/or diastolic blood pressure \> 90 mmHg confirmed by a repeat measurement on the same day)
* Subjects with a history of blood donation 3 months before study drug infusion
* Subjects with a history of exposure to antibodies 12 months before study drug infusion
* Subjects with previous exposure to anti-VEGF therapy
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT05110118
Study Brief:
Protocol Section:
NCT05110118